LEXARIA BIOSCIENCE CORP. (LEXX) Return on equity 2016–2025
LEXARIA BIOSCIENCE CORP. (LEXX) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-398.1%FY2025 · since FY2016: -480.1% → -398.1%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -398.1% | -326.0 pp |
| FY2024 | -72.1% | +146.8 pp |
| FY2023 | -218.9% | -127.5 pp |
| FY2022 | -91.5% | -60.6 pp |
| FY2021 | -30.8% | +133.7 pp |
| FY2020 | -164.6% | -329.2 pp |
| FY2019 | 164.6% | -111.7 pp |
| FY2018 | 276.4% | +346.1 pp |
| FY2017 | -69.7% | +410.4 pp |
| FY2016 | -480.1% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice